Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A single dose of peripherally infused EGFRvIII-directed C... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
0
Authors
Donald O’Rourke
20 more
Donald O’Rourke
•
MacLean Nasrallah
18 more
•
Marcela Maus
Published
July 19, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Science Translational Medicine
Topics
Biology
Cancer Oncology
Medicine
Immunology
Biomedical Engineering
Show all topics
DOI
10.1126/scitranslmed.aaa0984
